Cerebrolysin Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Adverse Reactions Caution For Usage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Full Prescribing Info

Adverse Reactions

Safety: The experience with Cerebrolysin during many years of clinical application, the information from post-marketing surveillance studies, the safety data from double-blind, placebo-controlled clinical trials and EVER's pharmacovigilance database demonstrate the excellent clinical safety profile of Cerebrolysin.
According to EMA classification (European Medicines Agency), Cerebrolysin is in the SAFE category.
In general, reported adverse drug reactions are transient and mild in intensity.
Cerebrolysin is safe and well tolerated.

View ADR Reporting Link

Cerebrolysin Adverse Reactions

Manufacturer:

Ever Pharma

Distributor:

Globo Asiatico